<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Acta Crystallogr D Biol Crystallogr</journal-id><journal-id journal-id-type="publisher-id">Acta Cryst. D</journal-id><journal-title>Acta Crystallographica Section D: Biological Crystallography</journal-title><issn pub-type="ppub">0907-4449</issn><issn pub-type="epub">1399-0047</issn><publisher><publisher-name>International Union of Crystallography</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18453690</article-id><article-id pub-id-type="pmc">2631105</article-id><article-id pub-id-type="publisher-id">hm5058</article-id><article-id pub-id-type="doi">10.1107/S0907444908004976</article-id><article-id pub-id-type="coden">ABCRE6</article-id><article-id pub-id-type="pii">S0907444908004976</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Papers</subject></subj-group></article-categories><title-group><article-title>Structure of a rabbit muscle fructose-1,6-bisphosphate aldolase A dimer variant</article-title><alt-title>Aldolase D128V</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Sherawat</surname><given-names>Manashi</given-names></name><xref ref-type="aff" rid="a">a</xref></contrib><contrib contrib-type="author"><name><surname>Tolan</surname><given-names>Dean R.</given-names></name><xref ref-type="aff" rid="b">b</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><contrib contrib-type="author"><name><surname>Allen</surname><given-names>Karen N.</given-names></name><xref ref-type="aff" rid="a">a</xref><xref ref-type="corresp" rid="cor">*</xref></contrib><aff id="a"><label>a</label>Department of Physiology and Biophysics, Boston University School of Medicine, 715 Albany Street, Boston, MA 02118-2394, <country>USA</country></aff><aff id="b"><label>b</label>Department of Biology, Boston University, 5 Cummington Street, Boston, MA 02215, <country>USA</country></aff></contrib-group><author-notes><corresp id="cor">Correspondence e-mail: <email>tolan@bu.edu</email>, <email>drkallen@bu.edu</email></corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>5</month><year>2008</year></pub-date><pub-date pub-type="epub"><day>19</day><month>4</month><year>2008</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>4</month><year>2008</year></pub-date><volume>64</volume><issue>Pt 5</issue><issue-id pub-id-type="publisher-id">d080500</issue-id><fpage>543</fpage><lpage>550</lpage><history><date date-type="received"><day>21</day><month>1</month><year>2008</year></date><date date-type="accepted"><day>22</day><month>2</month><year>2008</year></date></history><permissions><copyright-statement>&#x000a9; International Union of Crystallography 2008</copyright-statement><copyright-year>2008</copyright-year></permissions><self-uri xlink:type="simple" xlink:href="http://dx.doi.org/10.1107/S0907444908004976">A full version of this article is available from Crystallography Journals Online.</self-uri><abstract abstract-type="toc"><p>The X-ray crystallographic structure of a dimer variant of fructose-1,6-bisphosphate aldolase demonstrates a stable oligomer that mirrors half of the native tetramer. The presence of product demonstrates that this is an active form.</p></abstract><abstract><p>Fructose-1,6-bisphosphate aldolase (aldolase) is an essential enzyme in glycolysis and gluconeogenesis. In addition to this primary function, aldolase is also known to bind to a variety of other proteins, a property that may allow it to perform &#x02018;moonlighting&#x02019; roles in the cell. Although monomeric and dimeric aldolases possess full catalytic activity, the enzyme occurs as an unusually stable tetramer, suggesting a possible link between the oligomeric state and these noncatalytic cellular roles. Here, the first high-resolution X-ray crystal structure of rabbit muscle D128V aldolase, a dimeric form of aldolase mimicking the clinically important D128G mutation in humans associated with hemolytic anemia, is presented. The structure of the dimer was determined to 1.7&#x02005;&#x000c5; resolution with the product DHAP bound in the active site. The turnover of substrate to produce the product ligand demonstrates the retention of catalytic activity by the dimeric aldolase. The D128V mutation causes aldolase to lose intermolecular contacts with the neighboring subunit at one of the two interfaces of the tetramer. The tertiary structure of the dimer does not significantly differ from the structure of half of the tetramer. Analytical ultracentrifugation confirms the occurrence of the enzyme as a dimer in solution. The highly stable structure of aldolase with an independent active site is consistent with a model in which aldolase has evolved as a multimeric scaffold to perform other noncatalytic functions.</p></abstract><kwd-group><kwd>dimeric aldolase</kwd><kwd>hemolytic anemia</kwd><kwd>D128V</kwd><kwd>oligomerization</kwd></kwd-group></article-meta></front><body><sec sec-type="introduction" id="sec1"><label>1.</label><title>Introduction</title><p>Fructose-1,6-bisphosphate aldolase (aldolase; EC 4.1.2.13) is a ubiquitously expressed glycolytic enzyme that catalyzes the reversible cleavage of fructose 1,6-bisphosphate (Fru 1,6-P<sub>2</sub>) to dihydroxyacetone phosphate (DHAP) and glyceraldehyde 3-phosphate (G3P) in glycolysis and the reverse reaction in gluconeogenesis. In addition, aldolase is involved in the metabolism of fructose, converting fructose 1-phosphate (Fru 1-P) to DHAP and glyceraldehyde (Horecker <italic>et al.</italic>, 1975<xref ref-type="bibr" rid="bb19"> &#x025b6;</xref>).</p><p>There are two classes of aldolases based on their chemical mechanism: class I enzymes are cofactor-independent and catalyze C&#x02014;C bond cleavage <italic>via</italic> the formation of a Schiff-base intermediate with the sugar, whereas class II enzymes require a divalent metal ion for catalysis. The class I aldolases of vertebrates are further subdivided into three isozymes that have different activities and vary in their tissue distribution (Rutter, 1964<xref ref-type="bibr" rid="bb47"> &#x025b6;</xref>). The isoforms aldolase A (predominantly present in muscle) and aldolase C (in brain) have higher activity towards Fru 1,6-P<sub>2</sub> than towards Fru 1-P. Aldolase B (in liver) has equal turnover numbers for both Fru 1,6-P<sub>2</sub> and Fru 1-P, corresponding to its role in fructose metabolism in the liver (Penhoet &#x00026; Rutter, 1971<xref ref-type="bibr" rid="bb42"> &#x025b6;</xref>). The amino-acid sequences of these isozymes are highly conserved, predominantly at the subunit interface and the active site (Rottmann <italic>et al.</italic>, 1984<xref ref-type="bibr" rid="bb45"> &#x025b6;</xref>, 1987<xref ref-type="bibr" rid="bb44"> &#x025b6;</xref>; Lai <italic>et al.</italic>, 1974<xref ref-type="bibr" rid="bb27"> &#x025b6;</xref>; Deng &#x00026; Smith, 1999<xref ref-type="bibr" rid="bb12"> &#x025b6;</xref>), with 81, 70 and 70% overall sequence identity between A and C, between A and B and between B and C, respectively.</p><p>Biochemical studies supported by crystal structures have shown that class I aldolases are invariably present as homotetramers (Penhoet <italic>et al.</italic>, 1967<xref ref-type="bibr" rid="bb41"> &#x025b6;</xref>). Each subunit has an independent active site that resides in the center of the barrel in a (&#x003b1;/&#x003b2;)<sub>8</sub>-barrel fold (Sygusch <italic>et al.</italic>, 1987<xref ref-type="bibr" rid="bb51"> &#x025b6;</xref>). Although the quaternary structure is not required for enzymatic activity (Beernink &#x00026; Tolan, 1996<xref ref-type="bibr" rid="bb4"> &#x025b6;</xref>), the dissociation constant is unusually low, of the order of 10<sup>&#x02212;26</sup>&#x02005;            <italic>M</italic>            <sup>3</sup> for the monomer&#x02013;tetramer equilibrium (Tolan <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb53"> &#x025b6;</xref>). This dissociation constant is lower than those of other glycolytic enzymes and raises the question of why aldolase has evolved to possess such a very tight interaction at the protein&#x02013;protein interfaces. Steady-state kinetic studies of aldolase isozymes have shown no cooperativity among the subunits, thus aldolase does not display allosteric regulation (Penhoet &#x00026; Rutter, 1971<xref ref-type="bibr" rid="bb42"> &#x025b6;</xref>). Perhaps linked to these findings, there is considerable evidence that aldolase participates in nonmetabolic processes in addition to its enzymatic role. Aldolase is involved in binding interactions with several other proteins, but the functional role of aldolase in these interactions has not been fully characterized. Aldolases A and C have been found to bind to the neurofilament light-chain mRNA in neurons (Ca&#x000f1;ete-Soler <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb9"> &#x025b6;</xref>). Aldolase A associates with the vacuolar H<sup>+</sup>-ATPase (Lu <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb31"> &#x025b6;</xref>) and is thought to mediate its assembly, expression, and activity as a proton pump (Lu <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb32"> &#x025b6;</xref>). Aldolase also plays a role in the control of proteins involved in endocytosis (Lundmark &#x00026; Carlsson, 2004<xref ref-type="bibr" rid="bb33"> &#x025b6;</xref>). There are other binding partners for which no functional role has been established, including &#x003b3;-tubulin (Volker &#x00026; Knull, 1997<xref ref-type="bibr" rid="bb54"> &#x025b6;</xref>), heparin (Ta <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb52"> &#x025b6;</xref>), phospholipase D (Kim <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb23"> &#x025b6;</xref>) and the glucose transporter GLUT4 (Kao <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb22"> &#x025b6;</xref>). Aldolase A has been proposed to play a structural role in the assembly of the actin cytoskeleton <italic>in vivo</italic> owing to its well established ability to bind F-actin (Arnold &#x00026; Pette, 1968<xref ref-type="bibr" rid="bb2"> &#x025b6;</xref>; Arnold <italic>et al.</italic>, 1971<xref ref-type="bibr" rid="bb1"> &#x025b6;</xref>; O&#x02019;Reilly &#x00026; Clarke, 1993<xref ref-type="bibr" rid="bb38"> &#x025b6;</xref>). Further studies have shown that tetrameric aldolase can cross-link F-actin filaments into a gel or rafts, which is consistent with a potential role for this enzyme in the regulation of cytoskeleton structure (Pagliaro &#x00026; Taylor, 1988<xref ref-type="bibr" rid="bb40"> &#x025b6;</xref>; Wang <italic>et al.</italic>, 1996<xref ref-type="bibr" rid="bb55"> &#x025b6;</xref>; Sukow &#x00026; De&#x000ad;Rosier, 1998<xref ref-type="bibr" rid="bb50"> &#x025b6;</xref>). The ability to cross-link actin points to the multimeric state of aldolase as a prerequisite for its &#x02018;moonlighting&#x02019; functions, <italic>i.e.</italic> a single protein&#x02013;protein interface can thus provide multiple interactions.</p><p>Some of the activities of aldolase appear to link catalytic activity to quaternary structure. Aldolase A deficiency is an autosomal recessive trait and has been associated with nonspherocytic hemolytic anemia in humans (Beutler <italic>et al.</italic>, 1973<xref ref-type="bibr" rid="bb5"> &#x025b6;</xref>). One of the most well studied alleles, D128G (Kishi <italic>et al.</italic>, 1987<xref ref-type="bibr" rid="bb24"> &#x025b6;</xref>), results in a thermally unstable protein. The source of this instability has been studied further using this and other Asp128 substitutions (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>) and showed that the varying degrees of thermolability correlated with varying degrees of dissociation into dimers. The largest shift in the equilibrium towards the dimer is caused by the substitution of Asp128 by Val (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>). The structure of the aldolase tetramer and the position of Asp128 are shown in Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref>.</p><p>Here, using D128V aldolase, a high-resolution crystal structure of the dimeric form was explored. The data provided a structural basis for understanding the loss of quaternary structure and showed that the protein was stable in the dimeric form. Remarkably, the dimer did not differ significantly from the corresponding half-tetramer in native aldolases. Since the asymmetric unit contained a single monomer, analysis of D128V aldolase was performed <italic>via</italic> analytical ultracentrifugation to support the assignment of the crystallo&#x000ad;graphically generated dimer as the biological unit. The product DHAP was bound to the active site after crystallization with the substrate Fru 1,6-P<sub>2</sub>, which showed that D128V aldolase was catalytically competent. The crystal structure of the dimer will provide a structural basis for studies of aldolase in its role as a binding partner in cellular processes.</p></sec><sec sec-type="materials|methods" id="sec2"><label>2.</label><title>Materials and methods</title><sec id="sec2.1"><label>2.1.</label><title>Expression and purification of recombinant aldolase</title><p>D128V aldolase was purified as previously described (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>), with the exception that in the last step of purification the CM-Sepharose Fast Flow (GE Healthcare) column was washed with 50&#x02005;m<italic>M</italic> TAPS&#x02013;glycine&#x02013;KOH pH 8.3, 1&#x02005;m<italic>M</italic> dithiothreitol (DTT) and D128V aldolase was eluted with the same buffer containing 2&#x02005;m<italic>M</italic> Fru 1,6-P<sub>2</sub>. Activity was determined by following NADH oxidation at 340&#x02005;nm in a coupled assay with triosephosphate isomerase and glycerol-3-phosphate dehydrogenase (Racker, 1947<xref ref-type="bibr" rid="bb43"> &#x025b6;</xref>). The active fractions were concentrated and exchanged with crystallization buffer comprised of 50&#x02005;m<italic>M</italic> Tris&#x02013;HCl pH 7.0, 50&#x02005;m<italic>M</italic> NaCl, 25&#x02005;m<italic>M</italic> ammonium acetate using an Ultrafree centrifugal concentrator (Millipore) with a 10&#x02005;kDa molecular-weight cutoff membrane. The protein was&#x000a0;&#x0003e;95% pure as assessed by SDS&#x02013;PAGE.</p></sec><sec id="sec2.2"><label>2.2.</label><title>Crystallization, data collection and processing</title><p>D128V aldolase crystals were grown by the hanging-drop vapor-diffusion method using Hampton Research Crystal Screens I and II to screen initial crystallization conditions. The final optimized condition used a 1:1 ratio of protein in crystallization buffer to reservoir solution (0.2&#x02005;<italic>M</italic> ammonium sulfate, 25% PEG 2K monomethyl ether (PEG 2K MME), 100&#x02005;m<italic>M</italic> sodium acetate pH 5.1) with a final volume of 2&#x02005;&#x000b5;l, which was equilibrated against 0.5&#x02005;ml reservoir solution at 291&#x02005;K. The initial condition was optimized by the addition of osmolytes (naturally occurring compounds that affect protein stability; Bolen &#x00026; Baskakov, 2001<xref ref-type="bibr" rid="bb7"> &#x025b6;</xref>) to favor ordering in the C-&#x000ad;terminal region. The addition of 100&#x02005;m<italic>M</italic> sarcosine to the crystallization condition yielded pyramidal crystals with dimensions 0.1 &#x000d7; 0.05 &#x000d7; 0.05&#x02005;mm within 3&#x02005;d. X-ray diffraction data from D128V aldolase crystals were collected on beamline X29 at Brookhaven National Laboratory. The crystals were cryoprotected by passing them through Paratone-N prior to flash-freezing in a stream of gaseous N<sub>2</sub> at 100&#x02005;K. The programs <italic>DENZO</italic> and <italic>SCALEPACK</italic> (Otwinowski &#x00026; Minor, 1997<xref ref-type="bibr" rid="bb39"> &#x025b6;</xref>) were used to integrate and scale the data to a resolution of 1.70&#x02005;&#x000c5;. D128V aldolase crystallized in space group <italic>P</italic>2<sub>1</sub>2<sub>1</sub>2, with unit-cell parameters <italic>a</italic> = 53.32, <italic>b</italic> = 137.90, <italic>c</italic> = 50.15&#x02005;&#x000c5;. The data-collection statistics are summarized in Table 1<xref ref-type="table" rid="table1"> &#x025b6;</xref>.</p></sec><sec id="sec2.3"><label>2.3.</label><title>Structural solution and refinement</title><p>The structure was solved by molecular replacement with the program <italic>AMoRe</italic> (Navaza, 1994<xref ref-type="bibr" rid="bb37"> &#x025b6;</xref>) using a monomer from the structure of wild-type human muscle aldolase A (PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ald">1ald</ext-link>; Gamblin <italic>et al.</italic>, 1991<xref ref-type="bibr" rid="bb16"> &#x025b6;</xref>) as the initial search model. The orientation of the monomer obtained by molecular replacement was improved by rigid-body refinement using the <italic>Crystallography &#x00026; NMR System</italic> (<italic>CNS</italic>) program suite (Br&#x000fc;nger <italic>et al.</italic>, 1998<xref ref-type="bibr" rid="bb8"> &#x025b6;</xref>). &#x003c3;<sub>A</sub>-weighted electron-density maps with coefficients 2<italic>F</italic>               <sub>o</sub> &#x02212; <italic>F</italic>               <sub>c</sub> calculated from the model after rigid-body refinement in the program <italic>CNS</italic> showed good electron density for all areas of the monomer with the exception of the N-terminal (1&#x02013;&#x000ad;4) and C-terminal regions (345&#x02013;363), which failed to appear even after subsequent rounds of refinement. To minimize model bias in the electron-density maps, the side chain of residue 128 was modeled as an alanine. The density was clearly that of a valine in the 2<italic>F</italic>               <sub>o</sub> &#x02212; <italic>F</italic>               <sub>c</sub> map and was modeled as such in subsequent rounds of refinement. Iterative rounds of model building using <italic>Coot</italic> (Emsley &#x00026; Cowtan, 2004<xref ref-type="bibr" rid="bb13"> &#x025b6;</xref>) were performed alternately with rounds of positional, group temperature-factor and simulated-annealing refinement in the program <italic>CNS</italic>. A test set consisting of 10% of the data was used for <italic>R</italic>               <sub>free</sub> calculations. In the final rounds of refinement water molecules were included using a 3&#x003c3; cutoff. A total of 655 water molecules were added to the model as well as six sulfates which were bound at the surface of the protein. In the final round of refinement, a composite-omit electron-density map was used to fit the models of DHAP and sulfate to the active site. The final structure had a working <italic>R</italic> factor of 0.189 and a free <italic>R</italic> factor of 0.209. Analysis of the Ramachandran plot defined by <italic>PROCHECK</italic> (Laskowski <italic>et al.</italic>, 1993<xref ref-type="bibr" rid="bb28"> &#x025b6;</xref>) showed good statistics for the model, with 91.8% of residues in the most favorable regions and 8.2% of residues in additionally allowed regions for D128V aldolase.</p></sec><sec id="sec2.4"><label>2.4.</label><title>Analytical ultracentrifugation</title><p>Purified D128V aldolase was dialyzed against 0.2&#x02005;<italic>M</italic> ammonium sulfate, 100&#x02005;m<italic>M</italic> sodium acetate and 0.1&#x02005;m<italic>M</italic> DTT. The buffer was kept consistent with the crystallization buffer but with the exclusion of 25% PEG 2K MME, which forms a highly viscous solution that slows the equilibration process. Analytical ultracentrifugation (Beckman XLA-90, Beckman Coulter) was performed to determine the oligomerization state of D128V aldolase using 0.2, 0.5 and 1&#x02005;mg&#x02005;ml<sup>&#x02212;1</sup> aldolase at 6400, 8000 and 12&#x02005;000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> at 291&#x02005;K. The equilibrium state was verified at each speed and protein concentration was monitored at 280&#x02005;nm. A two-compartment pharmacokinetic model was fitted to individual data by means of the program <italic>WINNONLIN</italic> v.2.1 (Metzler, 1989<xref ref-type="bibr" rid="bb36"> &#x025b6;</xref>).</p></sec><sec id="sec2.5"><label>2.5.</label><title>Analysis of domain movement</title><p>The change in intersubunit orientation of the dimer in comparison to the tetramer was measured using the program <italic>DynDom</italic> (Hayward <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb18"> &#x025b6;</xref>). The buried surface area between monomers was calculated for the structures of aldolase (PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ado">1ado</ext-link>) and D128V aldolase using <italic>CNS</italic> with a probe radius of 1.4&#x02005;&#x000c5; (Lee &#x00026; Richards, 1971<xref ref-type="bibr" rid="bb30"> &#x025b6;</xref>).</p></sec></sec><sec sec-type="results" id="sec3"><label>3.</label><title>Results</title><sec id="sec3.1"><label>3.1.</label><title>Overall structure</title><p>The asymmetric unit contained a single monomer of D128V aldolase, with residues 5&#x02013;344 of the subunit modeled into electron density. The structure was refined to a resolution of 1.7&#x02005;&#x000c5; with a final <italic>R</italic> factor of 18.9% and an <italic>R</italic>               <sub>free</sub> of 21.0%. The first four N-terminal residues and the 19 C-terminal residues (345&#x02013;363) were disordered with no observable electron density, which is consistent with previously reported crystal structures (Sygusch <italic>et al.</italic>, 1987<xref ref-type="bibr" rid="bb51"> &#x025b6;</xref>; Choi <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb10"> &#x025b6;</xref>). Crystallo&#x000ad;graphic data-collection and refinement statistics are reported in Table 1<xref ref-type="table" rid="table1"> &#x025b6;</xref>. The structure of the monomer is not significantly different from that of wild-type aldolase, with an r.m.s. deviation of 0.50&#x02005;&#x000c5;. The density at the site of substitution was well accounted for, reflecting a change in the side chain with no molecular disorder in the region (Fig. 2<xref ref-type="fig" rid="fig2"> &#x025b6;</xref>).</p></sec><sec id="sec3.2"><label>3.2.</label><title>               <bold>Crystal-packing analysis</bold>            </title><p>The crystallographic asymmetric unit of the aldolase structure contained one monomer. Upon building the symmetry mates, the monomer formed a tightly packed dimer with its counterpart in the neighboring asymmetric unit. However, there were no counterparts of this symmetry dimer to form the native tetramer. Thus, the structure demonstrated a dimeric oligomerization state. The structural differences between the D128V aldolase dimer and the wild-type tetramer (PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ado">1ado</ext-link>) were not significant. An overlay of the main-chain C<sup>&#x003b1;</sup> atoms of the dimer with those of the wild-type aldolase A dimer (subunits <italic>B</italic> and <italic>C</italic>) gave an overall r.m.s. deviation of 0.81&#x02005;&#x000c5; (Fig. 3<xref ref-type="fig" rid="fig3"> &#x025b6;</xref>). The 19 residues in the C-&#x000ad;terminal region (residues 345&#x02013;363) were not included in the calculations owing to their lack of ordered structure. The difference in the relative orientations of the monomers within the D128V aldolase compared with half of the tetramer was analyzed using the program <italic>DynDom</italic> (Hayward <italic>et al.</italic>, 1997<xref ref-type="bibr" rid="bb18"> &#x025b6;</xref>). The conformational difference was measured by overlaying a single monomer from the D128V aldolase on one monomer of the aldolase tetramer and measuring the displacement of the second monomer, yielding a 4.1&#x000b0; rotation at the dimer interface. The result was largely a rigid-body movement of the monomer with the <italic>A</italic> interface of the dimer acting as a hinge axis.</p></sec><sec id="sec3.3"><label>3.3.</label><title>Analytical ultracentrifugation</title><p>Sedimentation-equilibrium analytical ultracentrifugation was employed to show that D128V aldolase is dimeric under the same conditions as those used for crystallization for X-ray crystallography. The data were a good fit to a monodisperse model with a molecular weight equal to that of the aldolase dimer, 79&#x02005;580 &#x000b1; 350&#x02005;Da (Fig. 4<xref ref-type="fig" rid="fig4"> &#x025b6;</xref>), which is nearly the same as the calculated molecular weight of 78&#x02005;388&#x02005;Da. The data were not consistent when a monomer or tetramer was used for fitting (fit not shown). These data confirm that D128V aldolase forms a dimer in solution.</p></sec><sec id="sec3.4"><label>3.4.</label><title>Subunit interface</title><p>The native aldolase is a homotetramer with two unique interfaces described as interface <italic>A</italic> and interface <italic>B</italic> (see Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref>). In contrast to the <italic>A</italic> interface, which is comprised of helix-packing interactions, the <italic>B</italic> interface exhibits loop&#x02013;loop interactions formed by ten buried hydrogen bonds (Table 2<xref ref-type="table" rid="table2"> &#x025b6;</xref>). At each <italic>B</italic> interface, six of the hydrogen bonds involve the carboxylate O atoms of Asp128 interacting with the backbone amides of three consecutive residues (Gly126, Leu127 and Asp128) of the neighboring subunit (Fig. 5<xref ref-type="fig" rid="fig5"> &#x025b6;</xref>). The hydrophobic side chain of valine cannot form hydrogen bonds. Thus, D128V aldolase retains only the <italic>A</italic> interface, consistent with a crystallographic dimer. The loop region flanking the substituted Asp128 residue shows no major displacement arising from the loss of these conserved hydrogen bonds.</p></sec><sec id="sec3.5"><label>3.5.</label><title>Calculation of the buried surface area</title><p>Calculation of the buried surface area for the tetramer (PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ado">1ado</ext-link>) showed extensive interactions between the monomer interfaces. The dimer interface buries 869&#x02005;&#x000c5;<sup>2</sup> of surface area, while the tetramer buries 3460&#x02005;&#x000c5;<sup>2</sup>. The buried surface area of D128V aldolase did not significantly differ from the same dimer interface of the tetramer (851&#x02005;&#x000c5;<sup>2</sup>). If the crystal contacts from adjacent dimers were included, a total value of 2146&#x02005;&#x000c5;<sup>2</sup> was obtained. There was a net loss of 1314&#x02005;&#x000c5;<sup>2</sup> surface area for the D128V aldolase dimer when compared with the tetramer. Thus, the crystal contacts do not compensate for the loss in buried surface area of the <italic>B</italic> interface. It is curious that D128V aldolase did not pack into the wild-type tetramer during crystallization. Certainly, there are no steric constraints to prevent this. In contrast, the dimeric aldolase B A149P variant (Malay <italic>et al.</italic>, 2002<xref ref-type="bibr" rid="bb35"> &#x025b6;</xref>) did form the tetramer in the crystalline state (Malay <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb34"> &#x025b6;</xref>).</p></sec><sec id="sec3.6"><label>3.6.</label><title>Active site</title><p>Numerous crystal structures of aldolase A bound to sub&#x000ad;strates or products have been determined (Blom &#x00026; Sygusch, 1997<xref ref-type="bibr" rid="bb6"> &#x025b6;</xref>; Choi <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb10"> &#x025b6;</xref>, 2001<xref ref-type="bibr" rid="bb11"> &#x025b6;</xref>) and have provided insight into aldolase substrate recognition and catalysis. The active site of rabbit muscle aldolase A is located in the center of the barrel and includes a number of conserved charged residues (Arg42, Lys107, Lys146, Glu187 and Arg303) that are in close proximity to the Schiff base-forming Lys229 (Lai <italic>et al.</italic>, 1965<xref ref-type="bibr" rid="bb26"> &#x025b6;</xref>). A molecule of the product DHAP and a sulfate ion were found liganded to the active site of the dimeric D128V aldolase (Fig.&#x000a0;6<xref ref-type="fig" rid="fig6"> &#x025b6;</xref>               <italic>a</italic>). The presence of the product was a consequence of the cleavage of Fru 1,6-P<sub>2</sub> (retained from the purification process, which included elution with substrate). The C1 phosphate was bound by hydrogen bonds to the &#x0220a;-amino group of Lys229 and the main-chain N atoms of Ser271 and Gly272 as is found in other aldolase&#x02013;DHAP structures (Blom &#x00026; Sygusch, 1997<xref ref-type="bibr" rid="bb6"> &#x025b6;</xref>; Choi <italic>et al.</italic>, 2001<xref ref-type="bibr" rid="bb11"> &#x025b6;</xref>; St-Jean <italic>et al.</italic>, 2007<xref ref-type="bibr" rid="bb48"> &#x025b6;</xref>). The C2 carbonyl and the C3 hydroxyl make hydrogen bonds to the Arg303 main-chain N atom and guanidino group, respectively. The sulfate ion binds to a site comprised of residues Arg303, Lys41 and Arg42, all of which are known to bind the C6 phosphate of Fru 1,6-P<sub>2</sub> (Choi <italic>et al.</italic>, 1999<xref ref-type="bibr" rid="bb10"> &#x025b6;</xref>; St-Jean <italic>et al.</italic>, 2005<xref ref-type="bibr" rid="bb49"> &#x025b6;</xref>). There was some displacement of residues Lys41, Arg42 and Arg303 in the D128V aldolase structure when compared with previously solved DHAP-liganded structures (Fig. 6<xref ref-type="fig" rid="fig6"> &#x025b6;</xref>               <italic>b</italic>) owing to their binding interaction with the sulfate ion.</p></sec></sec><sec sec-type="discussion|interpretation" id="sec4"><label>4.</label><title>Discussion</title><p>Fructose-1,6-bisphosphate aldolase has a highly conserved tetrameric structure with an atypical, low dissociation constant (Tolan <italic>et al.</italic>, 2003<xref ref-type="bibr" rid="bb53"> &#x025b6;</xref>). A possible explanation for this unusual stability is that it may have evolved as a tether molecule for roles in the cell other than those as a catalyst. The two interfaces in the quaternary structure (<italic>A</italic> and <italic>B</italic>) are highly conserved amongst aldolases from varied sources (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>, 1996<xref ref-type="bibr" rid="bb4"> &#x025b6;</xref>). The <italic>A</italic> interface is relatively hydrophobic, while the <italic>B</italic> interface is hydrophilic in nature and has buried hydrogen bonds making loop&#x02013;loop inter&#x000ad;actions. It has been shown previously that substitution at one of these interfaces leads to the dissociation of aldolase into dimers (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>). Monomers have been formed by making single mutations at each of the two interfaces. Both the monomeric and dimeric forms are fully active (Beernink &#x00026; Tolan, 1996<xref ref-type="bibr" rid="bb4"> &#x025b6;</xref>). Dissociation of the wild-type enzyme can only be accomplished under harsh conditions (Hsu &#x00026; Neet, 1973<xref ref-type="bibr" rid="bb20"> &#x025b6;</xref>, 1975<xref ref-type="bibr" rid="bb21"> &#x025b6;</xref>; Lebherz, 1972<xref ref-type="bibr" rid="bb29"> &#x025b6;</xref>; Rudolph <italic>et al.</italic>, 1976<xref ref-type="bibr" rid="bb46"> &#x025b6;</xref>; Gerschitz <italic>et al.</italic>, 1977<xref ref-type="bibr" rid="bb17"> &#x025b6;</xref>; Engelhard <italic>et al.</italic>, 1976<xref ref-type="bibr" rid="bb14"> &#x025b6;</xref>). Remarkably, previous studies of aldolase unfolding show that in 4&#x02005;<italic>M</italic> urea, although most of the backbone is unfolded, three short segments located at the subunit interface remain intact, maintaining the protein in a tetrameric state (Deng &#x00026; Smith, 1999<xref ref-type="bibr" rid="bb12"> &#x025b6;</xref>).</p><p>Mutations that lead to inborn errors in metabolism are often associated with the subunit interfaces. The human mutations D128G, E206K and G346S are associated with nonspherocytic hemolytic anemia and myopathy (Kishi <italic>et al.</italic>, 1987<xref ref-type="bibr" rid="bb24"> &#x025b6;</xref>; Kreuder <italic>et al.</italic>, 1996<xref ref-type="bibr" rid="bb25"> &#x025b6;</xref>; Esposito <italic>et al.</italic>, 2004<xref ref-type="bibr" rid="bb15"> &#x025b6;</xref>). Biochemical studies on the D128G substitution have shown that the consequence of substitution at position Asp128 is an active dimer that is thermolabile. Other substitutions at Asp128 showed that the tetramer&#x02013;dimer dissociation is shifted further to the right by the substitution of Asp128 by Val (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>) than by substitution by Gly or Ala.</p><p>The structure of D128V aldolase showed that this substitution yielded a stable dimer. There was a negligible perturbation in the tertiary structure of the monomers. Moreover, the <italic>A</italic> interface of the dimer was retained and did not differ significantly from that of the tetramer, indicating that the interactions were strong enough to maintain the stable dimer. The most compelling evidence was that at 291&#x02005;K the crystal-packing forces did not reform the tetramer although significant buried surface area was lost. The enzyme was stable enough to form a dimer in solution as observed <italic>via</italic> analytical ultracentrifugation. The strength of this interface is consistent with a potential role of the quaternary structure of aldolase as a tether molecule.</p><p>Finally, the presence of the product DHAP trapped in the active site after crystallization with Fru 1,6-P<sub>2</sub> was an indication that the enzyme remains catalytically active in the absence of its native tetrameric structure. Together, these results strongly suggest that the quaternary structure of native aldolase is crucial to the performance of its many other cellular roles.</p></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material position="float" xlink:type="simple"><p>PDB reference: <ext-link ext-link-type="pdb" xlink:href="3bv4" xlink:type="simple">fructose-1,6-bisphosphate aldolase A dimer variant, 3bv4, r3bv4sf</ext-link>            </p></supplementary-material></sec></body><back><ack><p>This work was supported by grants GM060616 (to DRT and KNA) and DK065089 (to DRT) from the National Institutes of Health. Data for this study were measured on beamline X29 of the National Synchrotron Light Source. Financial support for NSLS comes principally from the Offices of Biological and Environmental Research and of Basic Energy Sciences of the US Department of Energy and from the National Center for Research Resources of the National Institutes of Health. We thank Dr Nicholas Silvaggi for careful reading of this manuscript.</p></ack><ref-list><title>References</title><ref id="bb1"><citation citation-type="other">Arnold, H., Henning, R. &#x00026; Pette, D. (1971). <italic>Eur. J. Biochem.</italic><bold>22</bold>, 121&#x02013;126.</citation></ref><ref id="bb2"><citation citation-type="other">Arnold, H. &#x00026; Pette, D. (1968). <italic>Eur. J. Biochem.</italic><bold>6</bold>, 163&#x02013;171.</citation></ref><ref id="bb3"><citation citation-type="other">Beernink, P. T. &#x00026; Tolan, D. R. (1994). <italic>Protein Sci.</italic><bold>3</bold>, 1383&#x02013;1391.</citation></ref><ref id="bb4"><citation citation-type="other">Beernink, P. T. &#x00026; Tolan, D. R. (1996). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>93</bold>, 5374&#x02013;5379.</citation></ref><ref id="bb5"><citation citation-type="other">Beutler, E., Scott, S., Bishop, A., Margolis, N., Matsumoto, F. &#x00026; Kuhl, W. (1973). <italic>Trans. Assoc. Am. Physicians</italic>, <bold>86</bold>, 154&#x02013;166.</citation></ref><ref id="bb6"><citation citation-type="other">Blom, N. &#x00026; Sygusch, J. (1997). <italic>Nature Struct. Biol.</italic><bold>4</bold>, 36&#x02013;39.</citation></ref><ref id="bb7"><citation citation-type="other">Bolen, D. W. &#x00026; Baskakov, I. V. (2001). <italic>J. Mol. Biol.</italic><bold>310</bold>, 955&#x02013;963.</citation></ref><ref id="bb8"><citation citation-type="other">Br&#x000fc;nger, A. T., Adams, P. D., Clore, G. M., DeLano, W. L., Gros, P., Grosse-Kunstleve, R. W., Jiang, J.-S., Kuszewski, J., Nilges, M., Pannu, N. S., Read, R. J., Rice, L. M., Simonson, T. &#x00026; Warren, G. L. (1998). <italic>Acta Cryst.</italic> D<bold>54</bold>, 905&#x02013;921.</citation></ref><ref id="bb9"><citation citation-type="other">Ca&#x000f1;ete-Soler, R., Reddy, K. S., Tolan, D. R. &#x00026; Zhai, J. (2005). <italic>J. Neurosci.</italic><bold>25</bold>, 4353&#x02013;4364.</citation></ref><ref id="bb10"><citation citation-type="other">Choi, K. H., Mazurkie, A. S., Morris, A. J., Utheza, D., Tolan, D. R. &#x00026; Allen, K. N. (1999). <italic>Biochemistry</italic>, <bold>38</bold>, 12655&#x02013;12664.</citation></ref><ref id="bb11"><citation citation-type="other">Choi, K. H., Shi, J., Hopkins, C. E., Tolan, D. R. &#x00026; Allen, K. N. (2001). <italic>Biochemistry</italic>, <bold>40</bold>, 13868&#x02013;13875.</citation></ref><ref id="bb12"><citation citation-type="other">Deng, Y. &#x00026; Smith, D. L. (1999). <italic>J. Mol. Biol.</italic><bold>294</bold>, 247&#x02013;258.</citation></ref><ref id="bb13"><citation citation-type="other">Emsley, P. &#x00026; Cowtan, K. (2004). <italic>Acta Cryst.</italic> D<bold>60</bold>, 2126&#x02013;2132.</citation></ref><ref id="bb14"><citation citation-type="other">Engelhard, M., Rudolph, R. &#x00026; Jaenicke, R. (1976). <italic>Eur. J. Biochem.</italic><bold>67</bold>, 447&#x02013;453.</citation></ref><ref id="bb15"><citation citation-type="other">Esposito, G., Vitagliano, L., Costanzo, P., Borrelli, L., Barone, R., Pavone, L., Izzo, P., Zagari, A. &#x00026; Salvatore, F. (2004). <italic>Biochem. J.</italic><bold>380</bold>, 51&#x02013;56.</citation></ref><ref id="bb16"><citation citation-type="other">Gamblin, S. J., Davies, G. J., Grimes, J. M., Jackson, R. M., Littlechild, J. A. &#x00026; Watson, H. C. (1991). <italic>J. Mol. Biol.</italic><bold>219</bold>, 573&#x02013;576.</citation></ref><ref id="bb17"><citation citation-type="other">Gerschitz, J., Rudolph, R. &#x00026; Jaenicke, R. (1977). <italic>Biophys. Struct. Mech.</italic><bold>3</bold>, 291&#x02013;302.</citation></ref><ref id="bb18"><citation citation-type="other">Hayward, S., Kitao, A. &#x00026; Berendsen, H. J. (1997). <italic>Proteins</italic>, <bold>27</bold>, 425&#x02013;437.</citation></ref><ref id="bb19"><citation citation-type="other">Horecker, B. L., Tsolas, O. &#x00026; Lai, C. Y. (1975). <italic>The Enzymes</italic>, edited by P. D. Boyer, Vol. 7, pp. 213&#x02013;258. New York, London: Academic Press.</citation></ref><ref id="bb20"><citation citation-type="other">Hsu, L.-S. &#x00026; Neet, K. E. (1973). <italic>Biochemistry</italic>, <bold>12</bold>, 586&#x02013;595.</citation></ref><ref id="bb21"><citation citation-type="other">Hsu, L.-S. &#x00026; Neet, K. E. (1975). <italic>J. Mol. Biol.</italic><bold>97</bold>, 351&#x02013;357.</citation></ref><ref id="bb22"><citation citation-type="other">Kao, A. W., Noda, Y., Johnson, J. H., Pessin, J. E. &#x00026; Saltiel, A. R. (1999). <italic>J. Biol. Chem.</italic><bold>274</bold>, 17742&#x02013;17747.</citation></ref><ref id="bb23"><citation citation-type="other">Kim, J. H., Lee, S., Lee, T. G., Hirata, M., Suh, P. G. &#x00026; Ryu, S. H. (2002). <italic>Biochemistry</italic>, <bold>41</bold>, 3414&#x02013;3421.</citation></ref><ref id="bb24"><citation citation-type="other">Kishi, H., Mukai, T., Hirono, A., Fujii, H., Miwa, S. &#x00026; Hori, K. (1987). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>84</bold>, 8623&#x02013;8627.</citation></ref><ref id="bb25"><citation citation-type="other">Kreuder, J., Borkhardt, A., Repp, R., Pekrun, A., Gottsche, B., Gottschalk, U., Reichmann, H., Schachenmayr, W., Schlegel, K. &#x00026; Lampert, F. (1996). <italic>N. Engl. J. Med.</italic><bold>334</bold>, 1100&#x02013;1104.</citation></ref><ref id="bb26"><citation citation-type="other">Lai, C. Y., Hoffee, P. &#x00026; Horecker, B. L. (1965). <italic>Arch. Biochem. Biophys.</italic><bold>112</bold>, 567&#x02013;579.</citation></ref><ref id="bb27"><citation citation-type="other">Lai, C. Y., Nakai, N. &#x00026; Chang, D. (1974). <italic>Science</italic>, <bold>183</bold>, 1204&#x02013;1206.</citation></ref><ref id="bb28"><citation citation-type="other">Laskowski, R. A., MacArthur, M. W., Moss, D. S. &#x00026; Thornton, J. M. (1993). <italic>J. Appl. Cryst.</italic><bold>26</bold>, 283&#x02013;291.</citation></ref><ref id="bb29"><citation citation-type="other">Lebherz, H. (1972). <italic>Biochemistry</italic>, <bold>11</bold>, 2243&#x02013;2250.</citation></ref><ref id="bb30"><citation citation-type="other">Lee, B. &#x00026; Richards, F. M. (1971). <italic>J. Mol. Biol.</italic><bold>55</bold>, 379&#x02013;400.</citation></ref><ref id="bb31"><citation citation-type="other">Lu, M., Holliday, S., Zhang, L., Dunn, W. A. Jr &#x00026; Gluck, S. L. (2001). <italic>J. Biol. Chem.</italic><bold>276</bold>, 30407&#x02013;30413.</citation></ref><ref id="bb32"><citation citation-type="other">Lu, M., Sautin, Y. Y., Holliday, L. S. &#x00026; Gluck, S. L. (2004). <italic>J. Biol. Chem.</italic><bold>279</bold>, 8732&#x02013;8739.</citation></ref><ref id="bb33"><citation citation-type="other">Lundmark, R. &#x00026; Carlsson, S. R. (2004). <italic>J. Biol. Chem.</italic><bold>279</bold>, 42694&#x02013;42702.</citation></ref><ref id="bb34"><citation citation-type="other">Malay, A. D., Allen, K. N. &#x00026; Tolan, D. R. (2005). <italic>J. Mol. Biol.</italic><bold>347</bold>, 135&#x02013;144.</citation></ref><ref id="bb35"><citation citation-type="other">Malay, A. D., Procious, S. L. &#x00026; Tolan, D. R. (2002). <italic>Arch. Biochem. Biophys.</italic><bold>408</bold>, 295&#x02013;304.</citation></ref><ref id="bb36"><citation citation-type="other">Metzler, M. (1989). <italic>J. Chromatogr.</italic><bold>489</bold>, 11&#x02013;21.</citation></ref><ref id="bb37"><citation citation-type="other">Navaza, J. (1994). <italic>Acta Cryst.</italic> A<bold>50</bold>, 157&#x02013;163.</citation></ref><ref id="bb38"><citation citation-type="other">O&#x02019;Reilly, G. &#x00026; Clarke, F. (1993). <italic>FEBS Lett.</italic><bold>321</bold>, 69&#x02013;72.</citation></ref><ref id="bb39"><citation citation-type="other">Otwinowski, Z. &#x00026; Minor, W. (1997). <italic>Methods Enzymol.</italic><bold>276</bold>, 307&#x02013;326.</citation></ref><ref id="bb40"><citation citation-type="other">Pagliaro, L. &#x00026; Taylor, D. L. (1988). <italic>J. Cell Biol.</italic><bold>107</bold>, 981&#x02013;991.</citation></ref><ref id="bb41"><citation citation-type="other">Penhoet, E. E., Kochman, M., Valentine, R. &#x00026; Rutter, W. J. (1967). <italic>Biochemistry</italic>, <bold>6</bold>, 2940&#x02013;2949.</citation></ref><ref id="bb42"><citation citation-type="other">Penhoet, E. E. &#x00026; Rutter, W. J. (1971). <italic>J. Biol. Chem.</italic><bold>246</bold>, 318&#x02013;323.</citation></ref><ref id="bb43"><citation citation-type="other">Racker, E. (1947). <italic>J. Biol. Chem.</italic><bold>167</bold>, 843&#x02013;854.</citation></ref><ref id="bb44"><citation citation-type="other">Rottmann, W. H., Deselms, K. R., Niclas, J., Camerato, T., Holman, P. S., Green, C. J. &#x00026; Tolan, D. R. (1987). <italic>Biochimie</italic>, <bold>69</bold>, 137&#x02013;145.</citation></ref><ref id="bb45"><citation citation-type="other">Rottmann, W. H., Tolan, D. R. &#x00026; Penhoet, E. E. (1984). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>81</bold>, 2734&#x02013;2742.</citation></ref><ref id="bb46"><citation citation-type="other">Rudolph, R., Engelhard, M. &#x00026; Jaenicke, R. (1976). <italic>Eur. J. Biochem.</italic><bold>67</bold>, 455&#x02013;462.</citation></ref><ref id="bb47"><citation citation-type="other">Rutter, W. J. (1964). <italic>Fed. Proc.</italic><bold>23</bold>, 1248&#x02013;1257.</citation></ref><ref id="bb48"><citation citation-type="other">St-Jean, M., Izard, T. &#x00026; Sygusch, J. (2007). <italic>J. Biol. Chem.</italic><bold>282</bold>, 14309&#x02013;14315.</citation></ref><ref id="bb49"><citation citation-type="other">St-Jean, M., Lafrance-Vanasse, J., Liotard, B. &#x00026; Sygusch, J. (2005). <italic>J. Biol. Chem.</italic><bold>280</bold>, 27262&#x02013;27270.</citation></ref><ref id="bb50"><citation citation-type="other">Sukow, C. &#x00026; DeRosier, D. (1998). <italic>J. Mol. Biol.</italic><bold>284</bold>, 1039&#x02013;1050.</citation></ref><ref id="bb51"><citation citation-type="other">Sygusch, J., Beaudry, D. &#x00026; Allaire, M. (1987). <italic>Proc. Natl Acad. Sci. USA</italic>, <bold>84</bold>, 7846&#x02013;7850.</citation></ref><ref id="bb52"><citation citation-type="other">Ta, T. V., Takano, R., Kamei, K., Xu, X. Y., Kariya, Y., Yoshida, K. &#x00026; Hara, S. (1999). <italic>J. Biochem. (Tokyo)</italic>, <bold>125</bold>, 554&#x02013;559.</citation></ref><ref id="bb53"><citation citation-type="other">Tolan, D. R., Schuler, B., Beernink, P. T. &#x00026; Jaenicke, R. (2003). <italic>Biol. Chem.</italic><bold>384</bold>, 1463&#x02013;1471.</citation></ref><ref id="bb54"><citation citation-type="other">Volker, K. W. &#x00026; Knull, H. (1997). <italic>Arch. Biochem. Biophys.</italic><bold>338</bold>, 237&#x02013;243.</citation></ref><ref id="bb55"><citation citation-type="other">Wang, J., Morris, A. J., Tolan, D. R. &#x00026; Pagliaro, L. (1996). <italic>J. Biol. Chem.</italic><bold>271</bold>, 6861&#x02013;6865.</citation></ref></ref-list></back><floats-wrap><fig id="fig1" position="float"><label>Figure 1</label><caption><p>Rabbit muscle fructose-1,6-bisphophate aldolase tetramer (Blom &#x00026; Sygusch, 1997<xref ref-type="bibr" rid="bb6"> &#x025b6;</xref>; PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ado">1ado</ext-link>). Each monomer is colored separately, with the <italic>A</italic> and <italic>B</italic> interfaces indicated by arrows as described previously (Beernink &#x00026; Tolan, 1994<xref ref-type="bibr" rid="bb3"> &#x025b6;</xref>). The sites of the D128V substitutions are indicated by red spheres on interface <italic>B</italic> and the C- and N-termini are labeled for monomer <italic>A</italic>.</p></caption><graphic xlink:href="d-64-00543-fig1"/></fig><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Stereoview of the site of substitution in D128V aldolase. The residues flanking the site of substitution are shown with the corresponding 2<italic>F</italic>                  <sub>o</sub> &#x02212; <italic>F</italic>                  <sub>c</sub> electron-density map (blue cages) contoured at 1&#x003c3;.</p></caption><graphic xlink:href="d-64-00543-fig2"/></fig><fig id="fig3" position="float"><label>Figure 3</label><caption><p>Overlay of D128V aldolase (cyan) and wild-type aldolase (yellow). The C<sup>&#x003b1;</sup> traces are oriented as in Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref>.</p></caption><graphic xlink:href="d-64-00543-fig3"/></fig><fig id="fig4" position="float"><label>Figure 4</label><caption><p>Sedimentation-equilibrium analytical ultracentrifugation of D128V aldolase under crystallization conditions. The sedimentation-equilibrium trace using 20&#x02005;&#x000b5;<italic>M</italic> protein at 291&#x02005;K and 8000&#x02005;rev&#x02005;min<sup>&#x02212;1</sup> (monitored by absorbance at 280&#x02005;nm) is shown in the lower panel. The solid line depicts the best fit to the data (open circles) performed as described in &#x000a7;2.4<xref ref-type="sec" rid="sec2.4"/>. Residual errors are presented in the upper panel.</p></caption><graphic xlink:href="d-64-00543-fig4"/></fig><fig id="fig5" position="float"><label>Figure 5</label><caption><p>The <italic>B</italic> interface of wild-type aldolase A. Depiction of the hydrogen bonds (dashed lines) made with Asp128 at the <italic>B</italic> interface. The coloring scheme is identical to that of Fig. 1<xref ref-type="fig" rid="fig1"> &#x025b6;</xref> for the ribbons, with a ball-and-stick representation in yellow for one monomer and in orange for the second monomer.</p></caption><graphic xlink:href="d-64-00543-fig5"/></fig><fig id="fig6" position="float"><label>Figure 6</label><caption><p>Stereoview of the active site of fructose 1,6-bisphosphate. (<italic>a</italic>) DHAP and a sulfate ion depicted in ball-and-stick representation along with conserved active-site residues in D128V aldolase. A 1&#x003c3; electron-density map is shown (violet cages). (<italic>b</italic>) Superposition of the active-site residues of D128V aldolase in red with DHAP and sulfate ion in yellow and the residues of the wild-type DHAP-bound structure (Blom &#x00026; Sygusch, 1997<xref ref-type="bibr" rid="bb6"> &#x025b6;</xref>; PDB code <ext-link ext-link-type="uri" xlink:href="http://scripts.iucr.org/cgi-bin/cr.cgi?rm=pdb&#x00026;pdbId=1ado">1ado</ext-link>) in green. Hydrogen bonds are shown in black for D128V aldolase and in green for the wild-type structure.</p></caption><graphic xlink:href="d-64-00543-fig6"/></fig><table-wrap id="table1" position="float"><label>Table 1</label><caption><title>Crystallographic data-collection and refinement statistics</title><p>Values in parentheses are for the highest resolution shell.</p></caption><table frame="hsides" rules="groups"><tbody valign="top"><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Data-collection statistics</td><td style="" rowspan="1" colspan="1">&#x000a0;</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Unit-cell parameters (&#x000c5;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top"><italic>a</italic> = 53.32, <italic>b</italic> = 137.90, <italic>c</italic> = 51.15</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Space group</td><td style="" rowspan="1" colspan="1" align="left" valign="top"><italic>P</italic>2<sub>1</sub>2<sub>1</sub>2</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Wavelength (&#x000c5;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">1.10</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Resolution range (&#x000c5;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">100&#x02013;1.70</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Total reflections</td><td style="" rowspan="1" colspan="1" align="left" valign="top">267879 (24004)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Total unique reflections</td><td style="" rowspan="1" colspan="1" align="left" valign="top">42325 (4185)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Completeness (%)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">99.0 (100.0)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;                        <italic>I</italic>/&#x003c3;(<italic>I</italic>)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">44.4 (7.3)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;                        <italic>R</italic><sub>merge</sub><xref ref-type="table-fn" rid="tfn1">&#x02020;</xref></td><td style="" rowspan="1" colspan="1" align="left" valign="top">0.09 (0.4)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Redundancy</td><td style="" rowspan="1" colspan="1" align="left" valign="top">6.3 (5.7)</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Refinement statistics</td><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x000a0;</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;No. of protein atoms per ASU</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3029</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;No. of reflections (working set/free set)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">40471/4071</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;                        <italic>R</italic><sub>work</sub><xref ref-type="table-fn" rid="tfn2">&#x02021;</xref>/<italic>R</italic><sub>free</sub><xref ref-type="table-fn" rid="tfn3">&#x000a7;</xref> (%)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">0.189/0.209</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;Average <italic>B</italic> factors (&#x000c5;<sup>2</sup>)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x000a0;</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Overall</td><td style="" rowspan="1" colspan="1" align="left" valign="top">15.8</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Main-chain atoms</td><td style="" rowspan="1" colspan="1" align="left" valign="top">14.6</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Side-chain atoms</td><td style="" rowspan="1" colspan="1" align="left" valign="top">15.6</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;DHAP</td><td style="" rowspan="1" colspan="1" align="left" valign="top">26.6</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Active-site sulfate</td><td style="" rowspan="1" colspan="1" align="left" valign="top">45.1</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Surface sulfate</td><td style="" rowspan="1" colspan="1" align="left" valign="top">65.9</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Acetate</td><td style="" rowspan="1" colspan="1" align="left" valign="top">47.0</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Water</td><td style="" rowspan="1" colspan="1" align="left" valign="top">31.2</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;R.m.s. deviation from ideal</td><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x000a0;</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Bond lengths (&#x000c5;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">0.004</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Angles (&#x000b0;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">1.3</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Dihedrals (&#x000b0;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">21.5</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">&#x02003;&#x02003;Impropers (&#x000b0;)</td><td style="" rowspan="1" colspan="1" align="left" valign="top">0.92</td></tr></tbody></table><table-wrap-foot><fn id="tfn1"><label>&#x02020;</label><p>                     <italic>R</italic>                     <sub>merge</sub> = <inline-formula><inline-graphic xlink:href="d-64-00543-efi1.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>                     <inline-formula><inline-graphic xlink:href="d-64-00543-efi2.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>, where &#x02329;<italic>I</italic>(<italic>hkl</italic>)&#x0232a; is the mean intensity of the multiple <italic>I<sub>i</sub></italic>(<italic>hkl</italic>) observations of symmetry-related reflections.</p></fn><fn id="tfn2"><label>&#x02021;</label><p>                     <italic>R</italic>                     <sub>work</sub> = <inline-formula><inline-graphic xlink:href="d-64-00543-efi3.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>                     <inline-formula><inline-graphic xlink:href="d-64-00543-efi4.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>.</p></fn><fn id="tfn3"><label>&#x000a7;</label><p>                     <italic>R</italic>                     <sub>free</sub> = <inline-formula><inline-graphic xlink:href="d-64-00543-efi5.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>                     <inline-formula><inline-graphic xlink:href="d-64-00543-efi4.jpg" mimetype="image" mime-subtype="gif"/></inline-formula>, where the test set <italic>T</italic> includes 10% of the data.</p></fn></table-wrap-foot></table-wrap><table-wrap id="table2" position="float"><label>Table 2</label><caption><title>Interactions at interface <italic>B</italic>               </title></caption><table frame="hsides" rules="groups"><thead valign="bottom"><tr><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Monomer <italic>A</italic></th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Monomer <italic>B</italic></th><th style="border-bottom:1px solid black;" rowspan="1" colspan="1" align="left" valign="bottom">Distance (&#x000c5;)</th></tr></thead><tbody valign="top"><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Gln125&#x02005;CB</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Gly129&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.0</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Gly126&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD1</td><td style="" rowspan="1" colspan="1" align="left" valign="top">2.8</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Leu127&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.2</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.1</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD1</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Gly126&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">2.9</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">2.9</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Asp128&#x02005;OD2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Leu127&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.2</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Gly129&#x02005;N</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Gln125&#x02005;OE1</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.0</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Glu165&#x02005;OE1</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Asn168&#x02005;ND2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.0</td></tr><tr><td style="" rowspan="1" colspan="1" align="left" valign="top">Asn168&#x02005;ND2</td><td style="" rowspan="1" colspan="1" align="left" valign="top">Glu165&#x02005;OE1</td><td style="" rowspan="1" colspan="1" align="left" valign="top">3.0</td></tr></tbody></table></table-wrap></floats-wrap></article>